President and CEO Ned McCoy shared with Becker's some of the company's key objectives for the year, including the launch of some of the first medications from its Petersburg, Va.-based plant, the ...

Tandem Diabetes Care, Inc.’s TNDM fourth-quarter 2024 performance was driven by its impressive range of new products. The company’s impressive strategic initiatives provide a favorable opportunity for ...

Ruawai shearer Tommy Stevenson won a Senior final that included four of the Golden Shears Senior finalists, among them winner Bruce Grace, of Wairoa, who on Saturday had to settle for fifth place, and ...

Following the release of Skyscraper Stan's third studio album, Those Were Days, via Cheersquad Records & Tapes, Stan is excited to hit the road with his band, The Commission Flats, for a run of album ...

With thousands of press releases published each month, it can be difficult to keep up with everything on PR Newswire. To help ...

Biocon said that its wholly owned subsidiary, Biocon Biologics announced strategic collaboration agreement with Civica, Inc. to expand access, affordability of Insulin Aspart in the United States.

Biocon Biologics and Civica Inc. not-for-profit generic drug and pharmaceutical company founded in 2018 to address and resolve life-saving drug shortages and affordability, has inked a strategic ...

The global antidiabetics market is on a strong growth trajectory, with sales projected to soar from USD 106.3 billion in 2024 to USD 298.2 billion by 2034. This substantial increase reflects a robust ...

Civica will commercialize the medicine for patients in the United States, after completion of development work and clinical ...

Biocon Biologics Ltd and Civica, Inc. today announced a strategic collaboration agreement to expand access and affordability of Insulin Aspart in the United States.

The US Food and Drug Administration approved the first-ever rapid-acting insulin for reducing blood sugar levels. It calls ...

Biocon Biologics partners with Civica Inc to increase affordability and access to Insulin Aspart in the US, targeting the ...